[1]
El Wahed, S.A., Hassabou, N.F. and Hamouda, M.A. 2022. Anticancer Potential of Hesperidin against HEp-2 Laryngeal Carcinoma Cell Line in Comparison to Doxorubicin. Open Access Macedonian Journal of Medical Sciences. 10, A (Jul. 2022), 1300–1309. DOI:https://doi.org/10.3889/oamjms.2022.10603.